Chinese medicinal herbs for reducing endocrine therapy-induced side effects in patients with hormone receptor‐positive breast cancer: a systematic review and meta-analysis

References

• Aggelis V, Johnston SRD. 2019. Advances in endocrine-based therapies for estrogen receptor-positive metastatic breast cancer. Drugs. 79(17):1849–1866.
   PubMed Web of Science ®Google Scholar
• Bian WH, Li L, Zhang XQ, Yang J, Ying Y, Le YZ, Chen L, Cao DY. 2013. Shugan Tiaoyinyang Fang in ameliorating symptoms caused by tamoxifen after breast cancer surgery and improving the quality of life：aRCT. J Nanjing Univ Trad Chin Med. 29:529–531. Chinese.
   Google Scholar
• Boon HS, Olatunde F, Zick SM. 2007. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 7:4.
   PubMedGoogle Scholar
• Cai JY, Gan JW, Yue SB, Zhuo CL, Chen QT, Zhang GL, Jin Y. 2021. Effect of Fuzheng Xiaoliu decoction on quality of life, inflammatory factors and sex hormones in postmenopausal breast cancer endocrine therapy patients. Shenzhen J Integr Tradit Chin West Med. 31:71–74. Chinese.
   Google Scholar
• Cai LL, Guo Q, Cao WL, Wu Y, Guo ZN, Xu Y. 2018. Effect of Chaiguilongmu decoction in improving adverse reactions of endocrine therapy for breast cancer: a randomized double-blind controlled study. China Pharm. 27:16–19. Chinese.
   Google Scholar
• Cao Y, Chen Y, Wang P, Lu J, Han X, She J. 2021. Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency. Bioengineered. 12(2):10345–10362.
   PubMed Web of Science ®Google Scholar
• Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO. 2008. The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med. 14(8):1049–1055.
   PubMed Web of Science ®Google Scholar
• Condorelli R, Vaz-Luis I. 2018. Managing side effects in adjuvant endocrine therapy for breast cancer. Expert Rev Anticancer Ther. 18(11):1101–1112.
   PubMed Web of Science ®Google Scholar
• Cooke M, Mitchell M, Tiralongo E, Murfield J. 2012. Complementary and alternative medicine and critical care nurses: a survey of knowledge and practices in Australia. Aust Crit Care. 25(4):213–223.
   PubMed Web of Science ®Google Scholar
• Cui Y, Shu XO, Gao YT, Wen WQ, Ruan ZX, Jin F, Zheng W. 2004. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 85(3):263–270.
   PubMed Web of Science ®Google Scholar
• Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, et al. 2013. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 381(9869):805–816.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. 2019. Breast cancer statistics, 2019. CA Cancer J Clin. 69(6):438–451.
   PubMed Web of Science ®Google Scholar
• Ernst E. 2000. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 78:252–257.
   PubMed Web of Science ®Google Scholar
• Fu Y, Yun Q, Zhu XM. 2015. Influences of Heixiaoyao San combined with Shensiwei on clinical measures and quality of life in breast cancer patients with menopausal-like symptoms induced by tamoxifen. Oncol Progr. 13:541–544. Chinese.
   Google Scholar
• Gong J. 2019. 42 cases of perimenopausal syndrome after endocrine therapy of breast cancer treated with Guipi decoction. Chiang-hsi Chung I Yao. 50:38–40. Chinese.
   Google Scholar
• Gong LJ, Lv ZY, Ding XW, Shi J. 2019. Clinical study on Shugan Liangxue decoction in improving perimenopausal syndrome in the patients with breast cancer using postoperative medical castration. China Mod Doc. 57:127–130. Chinese.
   Google Scholar
• Guo L, Wu DL, Du XF. 2016. Effect of Modified Xiangbei Yangrong Tang based on differentiation in treating metastatic breast cancer treated. Chin J Exp Tradit Med Formulae. 22:160–164. Chinese.
   Google Scholar
• Guo Q, Yao C, Guo YF, Wang C. 2020. Effects of Guilu Sanhuang Decoction combined with calcium on bone metabolism in patients with breast cancer treated by endocrine therapy. Chin J Inf Tradit Chin Med. 27:41–45. Chinese.
   Google Scholar
• Harris P, Rees R. 2000. The prevalence of complementary and alternative medicine use among the general population: a systematic review of the literature. Complement Ther Med. 8(2):88–96.
   PubMed Web of Science ®Google Scholar
• Hu WD. 2018. Clinical Effect of Ruqing Tang combined with western medicine therapy for breast cancer of qi-yin deficiency type. New J Tradit Chin Med. 50:154–156. Chinese.
   Google Scholar
• Hu MX, Zhu CX, Xu QQ, Sun KF. 2020. Effect of Chaishao Jieyu decoction combined with Pingxiao capsule on the patients with luminal breast cancer after operation. J Hainan Med Univ. 26:1640–1644. Chinese.
   Google Scholar
• Huang XH, Liang RH, Su L, Guo W, Wang CJ. 2017. Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment. Cancer Biomark. 18(2):183–190.
   PubMed Web of Science ®Google Scholar
• Jiang H, Li M, Du K, Ma C, Cheng Y, Wang S, Nie X, Fu C, He Y. 2021. Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu decoction. Chin Med. 16(1):129.
   PubMed Web of Science ®Google Scholar
• Johnston S, Pippen J Jr, Pivot X, Lichinitser M, Sadeghi S, Dieras V, Gomez HL, Romieu G, Manikhas A, Kennedy MJ, et al. 2009. Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer. J Clin Oncol. 27(33):5538–5546.
   PubMed Web of Science ®Google Scholar
• Kim W, Lee WB, Lee JW, Min BI, Baek SK, Lee HS, Cho SH. 2015. Traditional herbal medicine as adjunctive therapy for breast cancer: A systematic review. Complement Ther Med. 23(4):626–632.
   PubMed Web of Science ®Google Scholar
• Kuo YT, Chang TT, Muo CH, Wu MY, Sun MF, Yeh CC, Yen HR. 2018. Use of complementary Traditional Chinese Medicines by adult cancer patients in Taiwan: a nationwide population-based study. Integr Cancer Ther. 17(2):531–541.
   PubMed Web of Science ®Google Scholar
• Lee YK, Lee EG, Kim HY, Lee Y, Lee SM, Suh DC, Yoo JI, Lee S. 2020. Osteoporotic fractures of the spine, hip, and other locations after adjuvant endocrine therapy with aromatase inhibitors in breast cancer patients: a meta-analysis. J Korean Med Sci. 35(46):e403.
   PubMed Web of Science ®Google Scholar
• Leggett S, Koczwara B, Miller M. 2015. The impact of complementary and alternative medicines on cancer symptoms, treatment side effects, quality of life, and survival in women with breast cancer–a systematic review. Nutr Cancer. 67(3):373–391.
   PubMed Web of Science ®Google Scholar
• Li CS, Li ZY. 2021. Clinical observation of Chaihu plus modified Longgu Muli decoction on perimenopausal syndrome of estrogen receptor-positive breast cancer caused by tamoxifen. Hebei J Tradit Chin Med. 43:1620–1623. Chinese.
   Google Scholar
• Li JJ, Liang LC. 2017. Clinical observation of aromatase inhibitor-associated osteopenia treated by Bushen therapy. J Shanxi Coll Tradit Chin Med. 18:27–29. Chinese.
   Google Scholar
• Li S, So TH, Tang G, Tan HY, Wang N, Ng BFL, Chan CKW, Yu EC, Feng Y. 2020. Chinese herbal medicine for reducing chemotherapy-associated side-effects in breast cancer patients: a systematic review and meta-analysis. Front Oncol. 10:599073.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu X, Bensussan A, Li P, Moylan E, Delaney G, McPherson L. 2016. Herbal medicine for hot flushes induced by endocrine therapy in women with breast cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016:1327251.
   PubMed Web of Science ®Google Scholar
• Li XR, Zhu JQ, Tong ZY. 2019. Effect of Rehmanniae decoction combined with auricular acupuncture on cognitive ability, hormone level, blood lipid and vitamin D content of patients with postmenopausal breast cancer. Chin Arch Tradit Chin Med. 37:246–249. Chinese.
   Google Scholar
• Liu H, Zhou L, Zhang QQ, Ling J, Zhang R, Liu LF. 2021. Influence of strengthening endocrine therapy of Jiawei Erxian decoction joint ovarian function suppression on quality of life, Traditional Chinese Medicine syndromes, blood lipids and sex hormones of breast cancer patient in pre-menopausal hormones with receptor-positive. Hebei J Tradit Chin Med. 43:283–287. Chinese.
   Google Scholar
• Molassiotis A, Fernández-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, et al. 2005. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 16(4):655–663.
   PubMed Web of Science ®Google Scholar
• Pei JW, Sun TZ. 2019. Clinical study of Danzhi Xiaoyao powder combined with Erxian decoction in the treatment of class II climacteric syndrome after endocrine therapy for breast cancer. Acta Chin Med. 34:1973–1976. Chinese.
   Google Scholar
• Porter D, Cochrane S, Zhu X. 2017. Current usage of Traditional Chinese Medicine for breast cancer-a narrative approach to the experiences of women with breast cancer in Australia-a pilot study. Medicines (Basel. 4(2):20.
   PubMedGoogle Scholar
• Qiu JS, Wu YY, Liu C. 2020. Clinical study of Baohe pill in treatment of dyslipidemia in endocrine therapy of breast cancer. Res Integr Tradit Chin West Med. 12:303–307. Chinese.
   Google Scholar
• Shi H, Dong J, Xu YB. 2017. Longniu Bugu decoction for prevention and treatment of bone loss caused by endocrine therapy of premenopausal breast cancer. Chin J Endocr Surg. 11:380–383. Chinese.
   Google Scholar
• Shi YF, Wei QL, Zhou LN. 2014. Yiyuan Shengjing decoction treat similar climacteric syndrome of breast cancer after treated with Tamoxifen. J Zhejiang Chin Med Univ. 38:1172–1182. Chinese.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA Cancer J Clin. 70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Sun Y. 2014. The role of Chinese medicine in clinical oncology. Chin J Integr Med. 20(1):3–10.
   PubMed Web of Science ®Google Scholar
• Sun XF, Liu H, He YN, Liu CJ, Cui SD. 2014. Fuzheng Xiaoai decoction 50 cases of syndrome endocrine treatment of breast cancer after operation. Chin J Exp Tradit Med Formulae. 20:192–195. Chinese.
   Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Tao ZH, Yu XW, Tong X, Fang MH, Jin YJ, Xu ZG, Su Q. 2020. Clinical observation on the treatment of perimenopausal like syndrome with breast cancer endocrine therapy by Yishen Kang’ai Fang. Smart Healthcare. 6:91–94. Chinese.
   Google Scholar
• Wang JC, Sun CH, Liu HM, Yan WH. 2013. Effects of the Tiaohe decoction on premenopausal breast cancer PR(＋) ER(＋) HER-2(－) endometrium. Clin J Chin Med. 5:15–16. Chinese.
   Google Scholar
• Wang WS, You JL, Xue Q. 2017. Efficacy observation of Yishen-chenqian formula treatment Tamoxifen side effects of endocrine stage of breast cancer. Shanxi J Tradit Chin Med. 33:23–25. Chinese.
   Google Scholar
• Wong CK, Bao YX, Wong EL, Leung PC, Fung KP, Lam CW. 2005. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med. 33(3):381–395.
   PubMed Web of Science ®Google Scholar
• Wu JP, Feng N, Li Y, Bei LM, Li XL, Liu Y, Shi Y, Gao BC, Yang BF. 2016. Experimental research on the effect of Ruqing decoction on the levels of the hormone for patients with breast cancer of Qi and Yin deficiency syndrome. Inf Tradit Chin Med. 33:53–56.
   Google Scholar
• Xia YP, Wang H. 2015. The clinical observation of the treatment of osteoporosis with Jintiange capsules in postmenopausal breast cancer patients after surgery. Chin J Osteoporos. 21:812–816. Chinese.
   Google Scholar
• Xiao H, Xi KJ, Fang NQ. 2019. Modified Zhibai Dihuang decoction alleviating the adverse reactions of letrozole in endocrine therapy for breast cancer. Contemporary Med. 25:9–12. Chinese.
   Google Scholar
• Yang HF, Luo H, Yang OO, Hu ZJ, He JL, Xu HB. 2016. Effects of Erzhi pills and Guizhi decoction for the reproductive hormone, modified Kupperman score and ki67 expression of premenopausal Luminal type breast cancer patients with tidal fever after treatment. China Med Her. 13:175–178. Chinese.
   Google Scholar
• Yin SY, Wei WC, Jian FY, Yang NS. 2013. Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med. 2013:302426.
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu X, Li J, He L, Tripathy D. 2007. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. Cochrane Database Syst Rev. 2007(2):CD004921.
   PubMedGoogle Scholar
• Zhang XP, Wang C, Wang QW, Cao SH, Shao XY, Liang S, Feng M, Wang HH, Yao C. 2020. Study on the effect of Sanhuang decoction on chronic stress and blood viscosity of breast cancer patients. Chin J Surg Oncol. 12:534–538. Chinese.
   Google Scholar
• Zhang CL, Zheng YL. 2012. Clinical study of Dan Zhi Xiao Yao San and Er Zhi Wan Jia Jian in treating the hormone therapy of breast cancer the clinical observation of after menopause syndrome. China J Chin Med. 27:6–8. Chinese.
   Google Scholar
• Zhong SS, Wan H, Li R, Mao JL, Qu WC, Lu YY, Zhang C. 2020. Clinical effect of spleen-tonifying and kidney-nourishing prescription in the prevention and treatment of aromatase inhibitor-induced arthralgia. J Anhui Univ Chin Med. 39:20–24. Chinese.
   Google Scholar
• Zhou J, Zhao F, Zhan XF. 2020. Clinical observation of similar climacteric syndrome due to breast cancer with endocrine therapy treated by Prosperous Ankun soup. Xinjiang J Tradit Chin Pharm. 38:6–9. Chinese.
   Google Scholar
• Zhu QL. 2017. Xianlinggubao capsules combined with calcium agents in treatment of osteoporosis due to hormonal therapy after breast cancer operation: effect on bone metabolism. Chin J Gen Surg. 26:670–674. Chinese.
   Google Scholar
• Zhu L, Li L, Li Y, Wang J, Wang Q. 2016. Chinese herbal medicine as an adjunctive therapy for breast cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016:9469276.
   PubMed Web of Science ®Google Scholar